| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |